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Abstract: Branched-chain amino acids (BCAA) in plasma are discussed as risk factors for the
onset of several diseases. Information about the contribution of the overall diet to plasma BCAA
concentrations is controversial. Our objective was to investigate which dietary pattern is associated
with plasma BCAA concentrations and whether other additional nutrients besides BCAA further
characterize this dietary pattern. Based on the cross-sectional KarMeN study, fasting plasma amino
acid (AA) concentrations, as well as current and habitual dietary intake were assessed in 298 healthy
individuals. Using reduced rank regression, we derived a habitual dietary pattern that explained
32.5% of plasma BCAA variation. This pattern was high in meat, sausages, sauces, eggs, and ice
cream but low in nuts, cereals, mushrooms, and pulses. The age, sex, and energy intake adjusted
dietary pattern score was associated with an increase in animal-based protein together with a decrease
in plant-based protein, dietary fiber, and an unfavorable fatty acid composition. Besides BCAA,
alanine, lysine and the aromatic AA were positively associated with the dietary pattern score as well.
All of these factors were reported to be associated with risk of type 2 diabetes and cardiovascular
diseases before. Our data suggest that rather than the dietary intake of BCAA, the overall dietary
pattern that contributes to high BCAA plasma concentrations may modulate chronic diseases risk.
Keywords: KarMeN study; BCAA; dietary pattern; AAA; protein source
1. Introduction
Diet is the only source of the essential branched-chain amino acids (BCAA) isoleucine, leucine,
and valine in humans. Dietary sources of these proteinogenic amino acids (AA) are protein-containing
foods, with meat and dairy being the main sources in omnivores [1,2]. Plasma BCAA concentrations
are furthermore influenced via catabolism of muscle protein. Due to their higher muscle mass, men are
reported to have higher BCAA levels compared to women. Further, obese compared to lean individuals,
as well as individuals consuming a high-protein and/or high-energy diet show higher plasma BCAA
concentrations [3].
There is insufficient and contradictory data on the contribution of diet to human plasma BCAA
concentrations. Rietman et al. recently concluded that about 80% of ingested dietary BCAA reach
the blood circulation [4], whereas studies investigating the kinetics of BCAA report less than 40%
absorption rate [5–7]. In contrast, observational studies reported only weak correlations between
dietary and plasma BCAA concentrations [1,8,9]. Furthermore, it is unclear whether plasma BCAA
concentrations may reflect short-term or long-term dietary intake [4].
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Several observational studies suggest that high plasma concentrations of BCAA are associated
with an increased risk of insulin resistance, type 2 diabetes (T2D) or cardiovascular diseases
(CVD) [1,3,10,11]. In contrast, some intervention studies reported independent positive associations
of BCAA with risk of future diabetes, but information on the composition of the overall diet as the
source of these essential AA is scarce. Other studies suggested that the observed associations between
BCAA and insulin resistance or T2D are only of correlative but not causal nature [12–14]. Nonetheless,
many questions remain as to whether these BCAA are causally related with the onset of these diseases,
and if causal, what the underlying mechanisms may be. It is as well currently unclear whether specific
BCAA-providing foods or dietary patterns determine circulating BCAA concentrations, or whether
host metabolism is the primary driver [15,16]. In particular, information on dietary patterns that
contribute to BCAA levels is lacking, although especially this information is highly relevant, because
BCAA are usually consumed within a dietary pattern and not as isolated nutrients. Zheng et al. [1]
reported a markedly attenuated association between BCAA intake and the observed risk of future
diabetes when adjusting for total protein intake—hinting for a role of the overall diet instead of an
isolated BCAA effect. Furthermore, Fontana et al. [17] stated that the AA composition of the diet rather
than the total protein intake affects metabolic health.
The aim of this study was therefore to identify a dietary pattern that determines plasma
BCAA concentrations, and to analyze whether further nutrients, such as other AA, are associated with
this dietary pattern. We hypothesized that nutrients beyond BCAA may contribute to the observed
increased disease risk of Western diets.
2. Materials and Methods
2.1. Study Design
The Karlsruhe Metabolomics and Nutrition (KarMeN) Study is a cross-sectional study conducted
at the Max Rubner-Institut in Karlsruhe, Germany, between 2011 and 2013, aiming to determine the
impact of a number of factors on the human metabolome in healthy men and women. Study design
and examination procedures are described in detail elsewhere [18]. In brief, a total of 312 voluntary
individuals aged 18 to 80 years were recruited. Exclusion criteria were smoking, acute or regular
medication including hormonal contraceptives for women, illness requiring treatment, supplement use,
and additionally for women pregnancy or breast-feeding. Each individual visited the study center
three times for a detailed characterization [18]. The study was conducted after approval of the local
ethics committee (State Medical Council of Baden-Württemberg) and according to the guidelines of the
Declaration of Helsinki. All participants gave written informed consent prior to study participation.
Participants were examined by trained study personnel according to standard operating
procedures, and anthropometric, clinical and functional parameters were assessed [18]. On the
second study center visit, participants provided a peripheral venous blood sample after an overnight
fast of at least 10 h using 9 mL EDTA plasma tubes (S-Monovette, Sarstedt, Nümbrecht, Germany).
Blood was centrifuged at 1850× g at 4 ◦C and aliquoted into small portions. In addition,
serum samples (S-Monovette Z-gel, Sarstedt, Nümbrecht, Germany) were collected for standard
clinical biochemistry analyses.
2.2. BCAA Measurement
A total of 21 AA (19 proteinogenic) were determined by an API 5500 Q-Trap mass spectrometer
(AB Sciex Germany GmbH, Darmstadt, Germany) coupled to a Shimadzu Nexera UHPLC-system in
fasting plasma samples using the Absolute IDQ™ p180 kit (Biocrates AG, Innsbruck, Austria). A 20 µL
plasma aliquot was used for each extraction. Protein precipitation and subsequent derivatization with
phenyl isothiocyanate was performed according to the manufacturer’s protocol prior to MS-detection.
For chromatographic separation of AA a Zorbax Eclipse XDB-C18 column (3× 100 mm, 3.5 µm; Agilent,
Waldbronn, Germany) equipped with a SecurityGuard™ column (C18, 4.0 × 3.0 mm; Phenomenex,
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Aschaffenburg, Germany) was used. A detailed description of the preparation and quantification
process can be found in Römisch-Margl et al. [19]. The Absolute IDQ™ kit provides optimized MS
instrument settings and compound parameters. System control and data acquisition was carried out
with Analyst 1.5.2 software. Quantification and data evaluation was done with the MetIDQ software
(version 4.5.2).
The p180 kit is validated by the manufacturer according to U.S. Food and Drug Administration
guidelines [20]. However, to ensure reliability of our results, quality control (QC)-samples included in
the kit were injected ten times distributed between the study samples. Additionally, in order to obtain
QC samples closely related to study samples (similar matrix and concentration), we also used pooled
study plasma. Six replicates of this study-specific QC sample were extracted per plate and evenly
distributed amongst the study samples. AA with a coefficient of variation (CV) of >20% in the QC
samples (pooled study plasma) were excluded from further analysis (glutamate and glycine), CVs for
the remaining AA ranged between 6.2% and 17.3% (see Table S1). Plasma BCAA refers to the single
concentrations of isoleucine, leucine, and valine plasma concentrations and not the sum of BCAA.
In subsequent tables and figures, AA are presented according to three-letter codes.
2.3. Dietary Assessment
Trained study personnel assessed the food intake of each individual (in g/day) on two
non-consecutive days at least 4 weeks apart in a personal and a telephone interview using 24 h
dietary recalls with the software EPIC-Soft [21,22]. Participants used standard units (such as slice
of bread, soup bowl), household measurements (such as tablespoon) and a picture booklet providing
photographs of portion sizes for various foods to indicate the consumed amount per meal. Additionally
participants were requested to fill in a food frequency questionnaire (FFQ). All reported foods were
then summarized into 35 food groups for further analysis (Table S2). Total energy intake (kcal/day)
and intake of nutrients were estimated based on data of the German food composition database
“Bundeslebensmittelschlüssel” (BLS, version 3.02) [23]. The BLS database includes data for total protein,
animal-based and plant-based protein; thus, daily intake of each protein source was the sum from
all food sources as well as from recipes of mixed dishes. Individual habitual intake of food groups
and nutrients was estimated using the NCI method [24,25]. Within this method, habitual intake was
estimated based on data of two 24 h recalls and FFQ information considering covariates age, sex, body
mass index (BMI), and weekend information (Monday–Thursday = weekday, Friday–Sunday = weekend).
2.4. Statistical Analysis
Food groups and BCAA were not normally distributed and were therefore univariate Box—Cox
transformed to approach normality [26] and z-standardized to ensure comparability prior to dietary
pattern analysis. We used an optimization step to find the best transformation parameter (exponent
lambda) between 0 and 2 for appropriate transformation of each variable; respective lambda values
are available in Table S3. Reduced Rank Regression (RRR) was used to extract dietary patterns.
RRR identifies linear functions of predictors (food groups) that explain as much response (BCAA)
variation as possible [27], where the number of derived linear functions depends on the number
of response variables (3 BCAA). The extracted RRR factor scores represent dietary patterns. We
extracted current dietary patterns based on data of the first 24 h recall covering the past 24 h of the
participants’ diet. Habitual dietary patterns were based on the calculated usual intakes representing
an average of a period of more than 4 weeks of the participants’ diet. For the adjusted dietary patterns,
we calculated univariate linear regression models with the RRR factor scores as dependent and age,
sex, and total energy intake as independent variables. The residuals of these models represent age, sex,
and energy intake adjusted dietary patterns, which were further investigated in subsequent analyses.
We used partial Spearman rank correlations adjusted for age, sex, and total energy intake to investigate
associations between the identified dietary pattern and the plasma AA profile. For descriptive statistics,
we built quartiles of the adjusted RRR factor scores. For macronutrients we calculated their percentage
Nutrients 2018, 10, 623 4 of 12
of total energy intake (E%). All statistical analyses were performed using software SAS Version 9.4
(SAS Institute, Cary, NC, USA) with p-values < 0.05 considered as statistically significant.
3. Results
3.1. Study Population
We excluded 11 individuals due to acute medication or illness requiring treatment. Individuals
with missing information for plasma BCAA (n = 1) or only one available 24 h recall (n = 2) were also
excluded from the analysis. The analytical study population includes 298 individuals, 171 men (57.4%)
and 127 women (42.6%) with a mean age of 44.5 and 51.6 years, respectively. Clinical parameters
were within the reference ranges. General characteristics of the study population separated by sex are
shown in Table 1.
Table 1. General characteristics of the KarMeN study population.
Men (n = 171) Women (n = 127)
Age (years) 44.5 ±17.9 51.6 ±15
Body weight (kg) 79.2 ±10.2 64.3 ±8.2
BMI (kg/m2) 24.4 ±2.7 23.1 ±2.9
Body fat (%) 23.0 ±6.4 33.4 ±6.6
Blood pressure (mmHg)
Systolic 128.3 ±14.2 120.3 ±17.7
Diastolic 84.8 ±10.6 83.4 ±12.0
Cholesterol (mg/dL)
HDL 62 ±14 77 ±16
LDL 123 ±41 129 ±35
Values are presented as arithmetic mean ± SD. Abbreviations: BMI, body mass index; HDL, high-density
lipoproteins; LDL, low-density lipoproteins; SD, standard deviation.
3.2. Dietary Pattern Analysis
With the RRR method we derived by default a total of 6 dietary patterns (3 current and 3 habitual
patterns, Table S4) that were positively correlated with the plasma BCAA concentrations. The first
derived current dietary pattern covering the diet of the past 24 h, showed 19.2% of explained variance
for BCAA plasma concentrations, whereas the first habitual dietary pattern, covering a period of more
than 4 weeks, explained 32.5%. The remaining 4 patterns from the RRR analysis explained only a
minor variation (<3.6%). Thus, we focused on the first pattern from the RRR of the habitual dietary
data for all further analyses because it explains the largest amount of variation among the BCAA.
This habitual dietary pattern correlated positively with food groups including meat, sausages,
sauces, eggs, and ice cream but inversely with nuts, cereals, mushrooms, and pulses (Table 2). The first
current dietary pattern was comparable with the first habitual dietary pattern showing consistent
positive correlations with meat, sausages, and sauces, and inverse correlations with nuts and seeds.
An overview of the average consumption of each investigated food group for the adjusted first habitual
dietary pattern is shown in Table S5.
Dividing our study group in four subgroups by the use of quartiles of the adjusted first habitual
dietary pattern score, we observed slight differences with regard to the macronutrient composition.
Between the lowest and highest quartile, we observed a mean difference of −2.7 E% for carbohydrates,
1.4 E% for fat and 0.8 E% for protein in the diet of the study participants (Table 3).
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Table 2. Partial Spearman correlation coefficients * of the RRR-derived first habitual dietary pattern
score with food groups adjusted for age, sex, and total energy intake.
Food Group (g/day) Spearmans’ rho p
Sauces 0.59 <0.0001
Sausages and meat products smoked 0.58 <0.0001
Meat and meat products unsmoked 0.56 <0.0001
Ice cream 0.29 <0.0001
Eggs 0.25 <0.0001
Cereals and cereal products −0.22 0.0001
Nuts and seeds −0.25 <0.0001
Mushrooms −0.26 <0.0001
Pulses −0.29 <0.0001
* Only correlations >|0.2| are shown.
Table 3. AA concentrations (µmol/L) and dietary nutrient composition by quartiles of adjusted habitual
dietary pattern score.
Variable
Q1 (n = 74) Q2 (n = 75) Q3 (n = 75) Q4 (n = 74)
Min Max Min Max Min Max Min Max p
Adjusted first habitual dietary pattern score −2.5 −0.43 −0.42 0.06 0.07 0.50 0.51 1.93 <0.0001
Mean ±SD Mean SD Mean SD Mean SD
Val 196.7 ±51.7 198.4 ±43.9 204.0 ±43.4 210.2 ±44.7 <0.0001
Leu 140.6 ±28.5 141.3 ±28.0 153.3 ±32.5 161.3 ±27.8 0.03
Ile 73.2 ±15.3 73.8 ±16.0 78.8 ±18.1 83.8 ±15.3 <0.0001
∑ BCAA 410.5 ±86.2 413.5 ±76.5 436.2 ±81.3 455.3 ±69.8 0.0002
Phe 55.9 ±8.2 56.7 ±6.7 59.0 ±8.1 60.1 ±8.9 0.0001
Trp 63.4 ±12.8 62.8 ±9.9 68.1 ±13.4 67.7 ±12.4 0.0010
Tyr 66.2 ±13.5 67.9 ±11.0 72.4 ±16.1 70.3 ±11.1 0.0003
∑ AAA 185.5 ±28.3 187.4 ±20.6 199.5 ±30.3 198.2 ±25.7 <0.0001
Energy intake (kcal/day) 2432 ±460 2350 ±464 2334 ±457 2474 ±497 0.90
Macronutrient intake (E%)
CHO 45.4 ±4.4 45.4 ±4.5 43.9 ±4.1 42.7 ±4.7 <0.0001
Monosaccharides 8.1 ±2.4 8.2 ±2.5 7.6 ±2.2 7.3 ±1.9 0.02
Disaccharides 11.7 ±2.2 12.4 ±2.4 11.9 ±2.3 11.6 ±2.3 0.75
Polysaccharides 23.1 ±3.1 22.5 ±3.7 22.1 ±3.5 21.7 ±4.1 0.003
Fat 36.7 ±4.1 36.7 ±3.9 37.4 ±3.7 38.1 ±3.8 0.001
SFA 15.7 ±2.5 15.9 ±2.2 16.6 ±2.3 16.5 ±2.0 0.0001
MUFA 12.2 ±1.5 12.2 ±1.7 12.5 ±1.4 13.1 ±1.8 <0.0001
PUFA 5.9 ±1.1 5.7 ±1.0 5.6 ±0.6 5.7 ±0.8 0.047
Protein 14.3 ±1.3 14.4 ±1.2 14.6 ±1.2 15.1 ±1.5 0.0015
Animal-based protein 6.5 ±1.6 7.2 ±1.3 7.6 ±1.4 8.4 ±1.5 <0.0001
Plant-based protein 5.2 ±1.0 4.9 ±0.8 4.7 ±0.7 4.5 ±0.7 <0.0001
Animal/plant protein ratio 1.3 ±0.5 1.5 ±0.5 1.7 ±0.5 1.9 ±0.4 <0.0001
Alcohol 2.41 ±1.92 2.09 ±2.07 3.43 ±2.96 2.95 ±2.71 0.05
Dietary fiber (g/MJ) 2.8 ±0.6 2.7 ±0.5 2.6 ±0.5 2.4 ±0.5 <0.0001
p-Values based on Spearman correlation analysis of each variable with the adjusted first dietary pattern score.
Abbreviations: AAA, aromatic amino acids; BCAA, branched-chain amino acids; CHO, carbohydrates; MUFA,
monounsaturated fatty acids; SFA, saturated fatty acids; PUFA, polyunsaturated fatty acids.
At the nutrient level, we observed a statistically significant decrease of mono- and polysaccharides,
of PUFAs, and of dietary fiber intakes, whereas the intake of SFAs and MUFAs was higher with an
increasing adjusted habitual dietary pattern score. Over all quartiles, study participants consumed
on average a higher amount of animal-based protein compared to plant-based protein. However,
the percentage of animal-based protein on total protein intake increased significantly, whereas the
percentage of plant-based protein intake decreased significantly with an increasing habitual dietary
pattern score (Table 3).
3.3. Associations of Plasma Amino Acid Concentrations with Dietary Pattern Score
Of the 17 investigated proteinogenic AA, we observed eight AA to be significantly correlated with
the age, sex, and energy intake adjusted habitual dietary pattern score. These included alanine, lysine,
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phenylalanine, tryptophan, tyrosine, and the BCAA leucine, isoleucine, and valine. The strongest
correlation besides the BCAA was observed for lysine followed by the three aromatic amino acids
(AAA) phenylalanine, tyrosine, and tryptophan, and alanine (Table 4). The sum of the AAA correlated
as well significantly with the habitual dietary pattern score.
Table 4. Spearman correlation coefficients of the RRR-derived first habitual dietary pattern with plasma
AA concentrations.
Spearmans’ rho p
Ala 0.15 0.01
Arg 0.01 0.89
Asn −0.10 0.09
Asp 0.01 0.82
Gln −0.02 0.70
His 0.01 0.82
Lys 0.23 <0.0001
Met 0.08 0.18
Orn 0.04 0.47
Phe 0.22 0.0001
Pro 0.08 0.18
Ser −0.03 0.67
Thr 0.04 0.51
Trp 0.17 0.003
Tyr 0.20 0.0005
Ile 0.31 <0.0001
Leu 0.33 <0.0001
Val 0.15 0.01
∑ BCAA 0.27 <0.0001
∑ AAA 0.23 <0.0001
Abbreviations: AAA, aromatic amino acids; BCAA, branched-chain amino acids.
Five of the first habitual dietary pattern associated AA showed significant positive correlations
with animal-based protein intake and at the same time significant inverse correlations with
plant-based protein intake (Figure 1). Alanine and tyrosine were inversely associated with plant-based
protein intake, whereas tryptophan was positively associated with animal-based protein intake.
Figure 1. Heat map of Spearman correlations between variables of dietary protein intake and
RRR-derived first habitual dietary pattern (crude and age, sex, energy intake adjusted) or selected
AA, respectively.
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4. Discussion
We have used RRR to identify dietary patterns that are correlated with plasma BCAA
concentrations. Furthermore, we investigated the macronutrient and overall AA composition of
the dietary pattern that explained the largest variation of plasma BCAA concentrations to identify
other nutrients associated with a BCAA-rich diet. To our knowledge, we are the first group to derive
an explicitly BCAA-associated dietary pattern and analyzed its composition.
4.1. Current vs. Habitual Diet
There is insufficient evidence whether plasma BCAA concentrations reflect short-term or
long-term dietary intake and protein intake, respectively [4,28]. Some studies observed a correlation
between dietary protein intake and plasma BCAA concentrations, whereas other studies did not [16,28].
In our study the identified first habitual dietary pattern explained more than 1.5 fold percentage
variation of plasma BCAA concentrations than a comparable current dietary pattern (see Table S4).
Furthermore, correlations between current protein intake and plasma BCAA concentrations were
consistently weaker compared to habitual protein intake (Figure 1). Consequently, circulating BCAA
are likely reflecting a long-term diet or a long-term BCAA intake, respectively, which is in line with
the literature, where in particular plasma concentrations of essential AA were more closely related to
habitual diet [29].
4.2. Plasma AA Concentrations and Dietary AA Composition
Compared to other healthy study populations, our study participants showed comparable plasma
concentrations for valine, but higher concentrations for leucine and isoleucine [3,30]. With regard
to populations with T2D or at high risk for CVD, plasma concentrations were comparable [3] or
higher [25] for leucine and isoleucine and at the same time lower for valine [3,30].
Plasma concentrations of the AAA were associated with the adjusted first habitual dietary pattern
score in our study. Other studies reported AAA (like the BCAA) to be associated with an increased
risk for T2D [31] and CVD [32]. Both, AAA and BCAA, were shown to be part of a metabolic profile
that discriminates between individuals with and without metabolic syndrome. However, the total AA
concentrations had only little discriminant power [33]. Clearly, a dietary pattern contributing to high
BCAA and AAA levels represents more than just the sum of its single components, enclosing as well
interactive effects of nutrients and other food constituents.
Besides BCAA and AAA, two other AA were correlated with the first habitual dietary pattern
score. Where BCAA have a key function in the skeletal muscle to provide nitrogen needed to maintain
pools of AA such as alanine [10,34], lysine is part of the dipeptide carnitine (a nutrient high in red meat).
With a carnitine and protein-rich diet, intake of lysine is increased and lysine-dependent biosynthesis
of carnitine is inhibited [35]. This may further explain the positive correlation with the habitual dietary
pattern in our study. As a consequence, a high intake of lysine may add to the increased risk for CVD
attributed to BCAA because a carnitine-rich diet has been associated with atherosclerosis and thus
CVD risk [36].
4.3. Dietary Protein Source of a BCAA-Rich Diet
Zheng et al. [1] observed markedly attenuated associations between BCAA levels and the risk
of T2D when adjusting for total protein intake—indicating that the total quantity of dietary protein
has a significant effect. We observed a positive correlation of the identified habitual dietary pattern
with both animal-based protein intake and the animal/plant protein ratio. Furthermore, the observed
associations between the dietary pattern and AA levels were robust and independent from total protein
intake (data not shown). Thus, not a high protein intake in general but the protein quality may play a
crucial role for modulating disease risk [16,17]. This is in line with other studies showing that not the
total protein intake itself but the protein composition or the AA pattern is important with regard to
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risk of T2D and CVD [37–39]. These results strengthen our hypothesis that the dietary pattern beyond
the intake of BCAA rather than the effect of BCAA intake itself contribute to the increased risk for
chronic diseases.
Dietary protein in Western diets has been reported to consist of >20% BCAA [34,40]. In our study,
in particular animal-based rather than plant-based protein was correlated with the BCAA-explaining
dietary pattern. This is in line with the literature, reporting BCAA levels to be highly dependent on the
protein source [1]. As a consequence, plasma BCAA levels may be a surrogate marker of a long-term
Western diet that is high in animal-based protein. The increased habitual intake of BCAA-rich foods
may further induce a higher steady-state of BCAA (e.g., deposition in muscle tissue and higher
turn-over rate) and subsequent increased plasma concentrations.
4.4. Additional Nutrients of a BCAA-Rich Diet
The identified habitual dietary pattern in our study is comparable to a Western diet [41,42] that is
typically high in processed foods such as meat, sausages, and foods with added sugar, and at the same
time low in vegetables and fruits. There is convincing evidence that a Western dietary pattern as a whole
is associated with an increased risk for chronic diseases such as T2D and CVD [43,44]. We observed
small but statistically significant trends regarding the intake of some nutrients with an increasing
habitual dietary pattern score. This included a higher intake of fat and in particular SFAs, accompanied
by a lower intake of dietary fiber. As this pattern represents a long-term dietary intake, metabolic
consequences may appear when consuming such diets over a long period. Thus, the identified
BCAA-explaining habitual dietary pattern comes along with an unfavorable nutrient composition.
4.5. Indirect Dietary Contributions
We observed a significant trend for a decreased intake in dietary fiber and plant-based protein
paralleled by a higher intake of animal-based protein with an increasing habitual dietary pattern score.
Dietary protein sources modulate risk factors for T2D and CVD [45,46]. There is convincing evidence
that among others dietary fiber intake and the dietary protein source modulate gut microbiome
composition [47–49], which additionally affects the risk for T2D and CVD [50]. Furthermore, some gut
bacteria are a possible source of BCAA via microbiota dependent intestinal biosynthesis [51]. Thus,
the habitual diet affects the composition and the metabolic capabilities of the intestinal microbiota,
which may in turn contribute to the metabolite pattern observed in plasma.
Unfortunately, we did not assess the participants’ microbiome composition. Nonetheless,
it is likely, that the observed dietary differences affect the microbiota composition and thus additionally
contribute to a long-term effect regarding T2D and CVD risk. This needs to be addressed in
further studies.
4.6. Limitations and Strengths
Our study has some limitations. Due to the cross-sectional design, we were not able to investigate
any causal or temporal relationship between diet and AA profiles. We included healthy and mostly
normal weight individuals. Therefore, dietary and lifestyle practices of our study participants may
differ from those of the general population. Generalizing our results should be limited to groups
with similar habits. As mentioned afore, we did not assess the gut microbiome composition of our
study participants.
On the other hand, this study has a number of strengths. All measures were highly standardized
according to standard operating procedures. Through the use of the NCI-method, we combined
information of 24 h recalls, a FFQ and diet-related covariates to investigate habitual dietary intake
instead of using solely FFQ data. Due to the strict inclusion criteria, we have a very health-conscious
and with regard to their diet and lifestyle very homogeneous study group without any disease
or medication. Therefore, we can exclude any interference of underlying diseases/medication.
We observed minor differences in the macronutrient composition which enables us to investigate
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differences in protein quality and origin. Within this nutritionally homogenous group, we could
observe small but significant differences in the dietary composition pointing at a potentially long-term
increase in disease risk. This needs to be addressed in further studies with a more heterogeneous
study group.
5. Conclusions
A high intake of BCAA is part of an unhealthy dietary pattern. This dietary pattern includes other
risk-associated factors such as higher intake of AAA as well as saturated fatty acids, and a decreased
intake of dietary fiber, all of which may contribute to the increased risk for T2D or CVD originally
attributed to the BCAA.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/10/5/623/s1,
Table S1: List of assessed amino acids with corresponding coefficient of variation of their respective quality
control samples, Table S2: Description of food groups, Table S3: Optimized lambda-values for Box—Cox
transformation of BCAA and habitual diet food groups, Table S4: RRR-derived current and habitual dietary
patterns with respective factor loadings of food groups and their explained variance for plasma BCAA
concentrations, Table S5: Average consumption of food groups with corresponding 95% confidence intervals by
quartiles of age, sex and energy intake adjusted dietary pattern score.
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